发明名称 |
Pharmaceutical compositions of Anisomelic acid and the use thereof |
摘要 |
A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided. |
申请公布号 |
US9623002(B2) |
申请公布日期 |
2017.04.18 |
申请号 |
US201514827343 |
申请日期 |
2015.08.17 |
申请人 |
Eriksson John E.;Paul Preethy;Peuhu Emilia;Akbarsha M. A. |
发明人 |
Eriksson John E.;Paul Preethy;Peuhu Emilia;Akbarsha M. A. |
分类号 |
A61K9/66;A61K38/00;A61K31/34;C07D307/00;A61K31/343;A61K9/00;A61K47/10;A61K47/26;A61K9/107;A61K47/44 |
主分类号 |
A61K9/66 |
代理机构 |
Seppo Laine Oy |
代理人 |
Seppo Laine Oy |
主权项 |
1. A method of treating Human Papilloma Virus mediated cancers in a human, comprising administering a therapeutically effective amount of Anisomelic acid or salts thereof to said human. |
地址 |
Turku FI |